Synergy1 Improves Biological Markers

May 5, 2008

1 Min Read
SupplySide Supplement Journal logo in a gray background | SupplySide Supplement Journal

VANDOEUVRE-LES-NANCY, France—In a recent French study, researchers found a lifelong intervention with an oligofructose-enriched insulin improved biological markers during ageing and lifespan in rats (Brit J Nutr. 2008) (DOI:10.1017/S0007114508975607). Male and female rats, three months old, were randomized to receive either a diet with 10 percent of an oligofructose-enriched inulin (as Beneo™Synergy1, from Orafti) or a standard diet (control) for 27 months. During the intervention period, male rats receiving Synergy1 (SYN1-M) displayed lower body weight, cholesterol and plasma triacylglycerolaemia, compared with the control group. The SYN1-M rats’, at 24 months old, survival rate was 35.3 percent greater than male control group. In female rats, the Synergy1 (SYN1-F) group also reduced body weight, cholesterol and triacylglycerolaemia levels, but the results were less consistent over the experiment. The survival rate in SYN1-F rats, 24 months old, was 33.3 percent greater to the female control group.

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like